Literature DB >> 7565135

Aspects of immunity for the AMA-1 family of molecules in humans and non-human primates malarias.

A W Thomas1, D Narum, A P Waters, J F Trape, C Rogier, A Gonçalves, V Rosario, P Druilhe, G H Mitchell, D Dennis.   

Abstract

The apical membrane antigen (AMA-1) family of malaria merozoite proteins is characterised by a high degree of inter-species conservation. Evidence that the protein (PK66/AMA-1) from the simian parasite Plasmodium knowlesi was protective in rhesus monkeys suggested that the 83kDa P. falciparum equivalent (PF83/AMA-1) should be investigated for protective effects in humans. Here we briefly review pertinent comparative data, and describe the use of an eukaryotic full length recombinant PF83/AMA-1 molecule to develop a sensitive ELISA for the determination of serological responses in endemic populations. The assay has revealed surprisingly high levels of humoral response to this quantitatively minor antigen. We also show that PK66/AMA-1 inhibitory mAb's are active against merozoites subsequent to release from schizont-infected red cells, further implicating AMA-1 molecules in red cell invasion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7565135     DOI: 10.1590/s0074-02761994000600016

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  9 in total

1.  posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.

Authors:  Birgitte Giersing; Kazutoyo Miura; Richard Shimp; Jin Wang; Hong Zhou; Andrew Orcutt; Anthony Stowers; Allan Saul; Louis H Miller; Carole Long; Sanjay Singh
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

2.  Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells.

Authors:  G H Mitchell; A W Thomas; G Margos; A R Dluzewski; L H Bannister
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1.

Authors:  Bart W Faber; Edmond J Remarque; William D Morgan; Clemens H M Kocken; Anthony A Holder; Alan W Thomas
Journal:  Infect Immun       Date:  2007-10-15       Impact factor: 3.441

4.  Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component.

Authors:  Cindy Tamminga; Martha Sedegah; David Regis; Ilin Chuang; Judith E Epstein; Michele Spring; Jose Mendoza-Silveiras; Shannon McGrath; Santina Maiolatesi; Sharina Reyes; Victoria Steinbeiss; Charlotte Fedders; Kathryn Smith; Brent House; Harini Ganeshan; Jennylynn Lejano; Esteban Abot; Glenna J Banania; Renato Sayo; Fouzia Farooq; Maria Belmonte; Jittawadee Murphy; Jack Komisar; Jackie Williams; Meng Shi; Donald Brambilla; Nalini Manohar; Nancy O Richie; Chloe Wood; Keith Limbach; Noelle B Patterson; Joseph T Bruder; Denise L Doolan; C Richter King; Carter Diggs; Lorraine Soisson; Daniel Carucci; Gail Levine; Sheetij Dutta; Michael R Hollingdale; Christian F Ockenhouse; Thomas L Richie
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

5.  Genetic diversity and population structure of genes encoding vaccine candidate antigens of Plasmodium vivax.

Authors:  Stella M Chenet; Lorena L Tapia; Ananias A Escalante; Salomon Durand; Carmen Lucas; David J Bacon
Journal:  Malar J       Date:  2012-03-14       Impact factor: 2.979

6.  Plasmodium knowlesi gene expression differs in ex vivo compared to in vitro blood-stage cultures.

Authors:  Stacey A Lapp; Sachel Mok; Lei Zhu; Hao Wu; Peter R Preiser; Zybnek Bozdech; Mary R Galinski
Journal:  Malar J       Date:  2015-03-13       Impact factor: 2.979

7.  Cytokine gene polymorphisms are not associated with anti-PvDBP, anti-PvAMA-1 or anti-PvMSP-119 IgG antibody levels in a malaria-endemic area of the Brazilian Amazon.

Authors:  Adriana A C Furini; Marcela P Capobianco; Luciane M Storti-Melo; Maristela G Cunha; Gustavo C Cassiano; Ricardo Luiz D Machado
Journal:  Malar J       Date:  2016-07-19       Impact factor: 2.979

8.  Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1.

Authors:  Dominika J Maskus; Michał Królik; Susanne Bethke; Holger Spiegel; Stephanie Kapelski; Melanie Seidel; Otchere Addai-Mensah; Andreas Reimann; Torsten Klockenbring; Stefan Barth; Rainer Fischer; Rolf Fendel
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

9.  Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination.

Authors:  Jason A Bailey; Andrea A Berry; Mark A Travassos; Amed Ouattara; Sarah Boudova; Emmanuel Y Dotsey; Andrew Pike; Christopher G Jacob; Matthew Adams; John C Tan; Ryan M Bannen; Jigar J Patel; Jozelyn Pablo; Rie Nakajima; Algis Jasinskas; Sheetij Dutta; Shannon Takala-Harrison; Kirsten E Lyke; Matthew B Laurens; Amadou Niangaly; Drissa Coulibaly; Bourema Kouriba; Ogobara K Doumbo; Mahamadou A Thera; Philip L Felgner; Christopher V Plowe
Journal:  Sci Rep       Date:  2020-03-03       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.